2015, ISBN 1451190212
eBook
European Urology, ISSN 0302-2838, 2016, Volume 70, Issue 1, pp. 93 - 105
Abstract The fourth edition of the World Health Organization (WHO) classification of urogenital tumours (WHO “blue book”), published in 2016, contains...
Urology | Urogenital tract | WHO classification | Male genital organs | SQUAMOUS-CELL-CARCINOMA | TUBULOCYSTIC CARCINOMA | DIFFERENTIATED PAPILLARY MESOTHELIOMA | SPERMATOCYTIC SEMINOMA | PRIMARY PURE TERATOMA | GERM-CELLS | UROLOGY & NEPHROLOGY | GONADAL STROMAL TUMOR | YOLK-SAC TUMOR | IN-SITU | CLINICOPATHOLOGICAL FEATURES | Neoplastic Syndromes, Hereditary - pathology | Uterine Neoplasms - pathology | Carcinoma, Squamous Cell - virology | Humans | Kidney Neoplasms - classification | Carcinoma, Renal Cell - classification | Male | Testicular Neoplasms - pathology | Neoplasm Grading | Leiomyomatosis - pathology | Carcinoma, Renal Cell - enzymology | Uterine Neoplasms - classification | Testicular Neoplasms - classification | Skin Neoplasms - pathology | Penile Neoplasms - virology | Papillomavirus Infections - complications | World Health Organization | Carcinoma, Renal Cell - pathology | Neoplasm Invasiveness | Leiomyomatosis - classification | Succinate Dehydrogenase - deficiency | Skin Neoplasms - classification | Carcinoma, Squamous Cell - classification | Neoplasms, Germ Cell and Embryonal - classification | Kidney Neoplasms - pathology | Penile Neoplasms - classification | Neoplastic Syndromes, Hereditary - classification | Neoplasms, Germ Cell and Embryonal - pathology | Medical colleges | Squamous cell carcinoma | Papillomavirus infections | Tumors
Urology | Urogenital tract | WHO classification | Male genital organs | SQUAMOUS-CELL-CARCINOMA | TUBULOCYSTIC CARCINOMA | DIFFERENTIATED PAPILLARY MESOTHELIOMA | SPERMATOCYTIC SEMINOMA | PRIMARY PURE TERATOMA | GERM-CELLS | UROLOGY & NEPHROLOGY | GONADAL STROMAL TUMOR | YOLK-SAC TUMOR | IN-SITU | CLINICOPATHOLOGICAL FEATURES | Neoplastic Syndromes, Hereditary - pathology | Uterine Neoplasms - pathology | Carcinoma, Squamous Cell - virology | Humans | Kidney Neoplasms - classification | Carcinoma, Renal Cell - classification | Male | Testicular Neoplasms - pathology | Neoplasm Grading | Leiomyomatosis - pathology | Carcinoma, Renal Cell - enzymology | Uterine Neoplasms - classification | Testicular Neoplasms - classification | Skin Neoplasms - pathology | Penile Neoplasms - virology | Papillomavirus Infections - complications | World Health Organization | Carcinoma, Renal Cell - pathology | Neoplasm Invasiveness | Leiomyomatosis - classification | Succinate Dehydrogenase - deficiency | Skin Neoplasms - classification | Carcinoma, Squamous Cell - classification | Neoplasms, Germ Cell and Embryonal - classification | Kidney Neoplasms - pathology | Penile Neoplasms - classification | Neoplastic Syndromes, Hereditary - classification | Neoplasms, Germ Cell and Embryonal - pathology | Medical colleges | Squamous cell carcinoma | Papillomavirus infections | Tumors
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 02/2015, Volume 39, Issue 2, pp. 251 - 259
Sarcomatoid neoplasms in patients with testicular germ cell tumors (TGCTs) may show diverse lineages and are usually attributed to “transformation” of...
yolk sac tumor | sarcoma | sarcomatoid | immunohistochemistry SALL4 | testicular neoplasms | glypican-3 | chemotherapy | germ cell tumor | SURGERY | MARKER | COMPONENTS | PATHOLOGY | CANCER | MALIGNANT-TRANSFORMATION | SALL4 | TERATOMA | TESTIS | immuno-histochemistry | EXPRESSION | Immunohistochemistry | Endodermal Sinus Tumor - drug therapy | Biomarkers, Tumor - analysis | Humans | Male | Testicular Neoplasms - pathology | Neoplasm Recurrence, Local - pathology | Young Adult | Testicular Neoplasms - drug therapy | Adolescent | Adult | Endodermal Sinus Tumor - pathology | Neoplasms, Germ Cell and Embryonal - drug therapy | Cell Transformation, Neoplastic - drug effects | Cell Transformation, Neoplastic - pathology | Neoplasms, Germ Cell and Embryonal - pathology | Index Medicus
yolk sac tumor | sarcoma | sarcomatoid | immunohistochemistry SALL4 | testicular neoplasms | glypican-3 | chemotherapy | germ cell tumor | SURGERY | MARKER | COMPONENTS | PATHOLOGY | CANCER | MALIGNANT-TRANSFORMATION | SALL4 | TERATOMA | TESTIS | immuno-histochemistry | EXPRESSION | Immunohistochemistry | Endodermal Sinus Tumor - drug therapy | Biomarkers, Tumor - analysis | Humans | Male | Testicular Neoplasms - pathology | Neoplasm Recurrence, Local - pathology | Young Adult | Testicular Neoplasms - drug therapy | Adolescent | Adult | Endodermal Sinus Tumor - pathology | Neoplasms, Germ Cell and Embryonal - drug therapy | Cell Transformation, Neoplastic - drug effects | Cell Transformation, Neoplastic - pathology | Neoplasms, Germ Cell and Embryonal - pathology | Index Medicus
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 09/2017, Volume 41, Issue 9, pp. 1290 - 1297
We report a unique case of gonadal mixed germ cell tumor (GCT) composed of a predominantly spermatocytic tumor (ST)-like component and a minor component of...
ovary | gonadoblastoma | germinoma | spermatocytic tumor-like | germ cell tumor | gonad | SURGERY | NEOPLASMS | 46,XX KARYOTYPE | OVARIAN GONADOBLASTOMA | YOUNG-PATIENTS | PATHOLOGY | TRUE HERMAPHRODITE | DIAGNOSTIC MARKER | germinoma spermatocytic tumor-like | YOLK-SAC TUMOR | DYSGERMINOMA | SEMINOMA | EXPRESSION | Neoplasms, Multiple Primary - genetics | Humans | Ovarian Neoplasms - pathology | Neoplasms, Germ Cell and Embryonal - genetics | Pregnancy Complications, Neoplastic - pathology | Chromosomes, Human, X | Ovarian Neoplasms - genetics | Pregnancy | Young Adult | Pregnancy Complications, Neoplastic - genetics | Germinoma - genetics | Phenotype | Germinoma - pathology | Gonadoblastoma - genetics | Karyotyping | Gonadoblastoma - pathology | Female | Neoplasms, Germ Cell and Embryonal - pathology
ovary | gonadoblastoma | germinoma | spermatocytic tumor-like | germ cell tumor | gonad | SURGERY | NEOPLASMS | 46,XX KARYOTYPE | OVARIAN GONADOBLASTOMA | YOUNG-PATIENTS | PATHOLOGY | TRUE HERMAPHRODITE | DIAGNOSTIC MARKER | germinoma spermatocytic tumor-like | YOLK-SAC TUMOR | DYSGERMINOMA | SEMINOMA | EXPRESSION | Neoplasms, Multiple Primary - genetics | Humans | Ovarian Neoplasms - pathology | Neoplasms, Germ Cell and Embryonal - genetics | Pregnancy Complications, Neoplastic - pathology | Chromosomes, Human, X | Ovarian Neoplasms - genetics | Pregnancy | Young Adult | Pregnancy Complications, Neoplastic - genetics | Germinoma - genetics | Phenotype | Germinoma - pathology | Gonadoblastoma - genetics | Karyotyping | Gonadoblastoma - pathology | Female | Neoplasms, Germ Cell and Embryonal - pathology
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 13, pp. 1442 - 1450
Summary Background Poor prognosis germ-cell tumours are only cured in about half of patients. We aimed to assess whether treatment intensification based on an...
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST CYCLE | ETOPOSIDE | THERAPY | SOUTHWEST-ONCOLOGY-GROUP | CISPLATIN | ONCOLOGY | DENSE CHEMOTHERAPY | HIGH-DOSE CHEMOTHERAPY | COMPLETE-RESPONSE | CANCER | Testicular Neoplasms - mortality | Prognosis | Follow-Up Studies | Peritoneal Neoplasms - blood | Humans | Middle Aged | Male | Mediastinal Neoplasms - mortality | Neoplasms, Germ Cell and Embryonal - blood | Testicular Neoplasms - pathology | Cisplatin - administration & dosage | Young Adult | Mediastinal Neoplasms - drug therapy | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Peritoneal Neoplasms - drug therapy | Oxaliplatin | Chorionic Gonadotropin - blood | Adult | Female | Neoplasms, Germ Cell and Embryonal - drug therapy | Paclitaxel - administration & dosage | Precision Medicine | alpha-Fetoproteins - metabolism | Peritoneal Neoplasms - pathology | Lenograstim | Mediastinal Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - mortality | Etoposide - administration & dosage | Survival Rate | Bleomycin - administration & dosage | Peritoneal Neoplasms - mortality | Recombinant Proteins - administration & dosage | Biomarkers, Tumor - blood | Ifosfamide - administration & dosage | International Agencies | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Adolescent | Aged | Neoplasm Staging | Testicular Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - pathology | Granulocyte Colony-Stimulating Factor - administration & dosage | Chemotherapy | Tumors | Cancer | Analysis
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST CYCLE | ETOPOSIDE | THERAPY | SOUTHWEST-ONCOLOGY-GROUP | CISPLATIN | ONCOLOGY | DENSE CHEMOTHERAPY | HIGH-DOSE CHEMOTHERAPY | COMPLETE-RESPONSE | CANCER | Testicular Neoplasms - mortality | Prognosis | Follow-Up Studies | Peritoneal Neoplasms - blood | Humans | Middle Aged | Male | Mediastinal Neoplasms - mortality | Neoplasms, Germ Cell and Embryonal - blood | Testicular Neoplasms - pathology | Cisplatin - administration & dosage | Young Adult | Mediastinal Neoplasms - drug therapy | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Peritoneal Neoplasms - drug therapy | Oxaliplatin | Chorionic Gonadotropin - blood | Adult | Female | Neoplasms, Germ Cell and Embryonal - drug therapy | Paclitaxel - administration & dosage | Precision Medicine | alpha-Fetoproteins - metabolism | Peritoneal Neoplasms - pathology | Lenograstim | Mediastinal Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - mortality | Etoposide - administration & dosage | Survival Rate | Bleomycin - administration & dosage | Peritoneal Neoplasms - mortality | Recombinant Proteins - administration & dosage | Biomarkers, Tumor - blood | Ifosfamide - administration & dosage | International Agencies | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Adolescent | Aged | Neoplasm Staging | Testicular Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - pathology | Granulocyte Colony-Stimulating Factor - administration & dosage | Chemotherapy | Tumors | Cancer | Analysis
Journal Article
Annals of Thoracic Surgery, ISSN 0003-4975, 2016, Volume 101, Issue 4, pp. e125 - e125
Surgery | Cardiothoracic Surgery | SURGERY | RESPIRATORY SYSTEM | CARDIAC & CARDIOVASCULAR SYSTEMS | Diagnosis, Differential | Heart Atria | Humans | Male | Tomography, X-Ray Computed | Heart Neoplasms - diagnosis | Positron-Emission Tomography | Magnetic Resonance Imaging, Cine | Tachycardia - etiology | Heart Neoplasms - complications | Neoplasms, Germ Cell and Embryonal - diagnosis | Tachycardia - diagnosis | Heart Neoplasms - surgery | Thoracic Surgery, Video-Assisted | Adult | Neoplasms, Germ Cell and Embryonal - complications | Cardiac Surgical Procedures - methods | Neoplasms, Germ Cell and Embryonal - surgery | Tachycardia | Tumors
Journal Article
7.
Full Text
Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors
Human Pathology, ISSN 0046-8177, 11/2018, Volume 81, pp. 26 - 36
Identification of the yolk sac tumor (YST) component in germ cell tumors (GCT) may prove challenging, and highly sensitive and specific immunohistochemical...
Germ cell tumor | Immunohistochemistry | Hepatocyte nuclear factor 1 | Yolk sac tumor | Embryonal carcinoma | BIOMARKER | MARKER | ZBTB16 | DISTINCT | PATTERNS | PATHOLOGY | HEPATOCYTE NUCLEAR FACTOR-1 | HEPATOCELLULAR-CARCINOMA | GASTRIC-CARCINOMA | SALL4 | EXPRESSION | Lymphatic system | Chemotherapy | Liver | Cloning | Metastasis | Localization | Patients | Tumors | Stains & staining
Germ cell tumor | Immunohistochemistry | Hepatocyte nuclear factor 1 | Yolk sac tumor | Embryonal carcinoma | BIOMARKER | MARKER | ZBTB16 | DISTINCT | PATTERNS | PATHOLOGY | HEPATOCYTE NUCLEAR FACTOR-1 | HEPATOCELLULAR-CARCINOMA | GASTRIC-CARCINOMA | SALL4 | EXPRESSION | Lymphatic system | Chemotherapy | Liver | Cloning | Metastasis | Localization | Patients | Tumors | Stains & staining
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10029, pp. 1762 - 1774
Summary Testicular germ cell tumours are at the crossroads of developmental and neoplastic processes. Their cause has not been fully elucidated but differences...
Internal Medicine | LYMPH-NODE DISSECTION | CARCINOMA-IN-SITU | MEDICINE, GENERAL & INTERNAL | LONG-TERM SURVIVORS | RANDOMIZED PHASE-III | SUBCENTIMETER RESIDUAL MASS | FOLLOW-UP | HIGH-DOSE CHEMOTHERAPY | CANCER-STUDY-GROUP | OF-THE-LITERATURE | MEDICAL-RESEARCH-COUNCIL | Testicular Neoplasms - therapy | ras Proteins - genetics | Genome-Wide Association Study | Testicular Neoplasms - genetics | Humans | Neoplasms, Germ Cell and Embryonal - epidemiology | Male | Neoplasms, Germ Cell and Embryonal - genetics | Testicular Neoplasms - epidemiology | Orchiectomy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins c-kit - genetics | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Neoplasms, Germ Cell and Embryonal - therapy | Chemotherapy | Disease susceptibility | Epidemiology | Genomics | Cancer | Tumors | Pathogenesis | Medical prognosis | Genetics | Mutation | Health risk assessment | Testicular cancer | Cancer therapies | Risk factors
Internal Medicine | LYMPH-NODE DISSECTION | CARCINOMA-IN-SITU | MEDICINE, GENERAL & INTERNAL | LONG-TERM SURVIVORS | RANDOMIZED PHASE-III | SUBCENTIMETER RESIDUAL MASS | FOLLOW-UP | HIGH-DOSE CHEMOTHERAPY | CANCER-STUDY-GROUP | OF-THE-LITERATURE | MEDICAL-RESEARCH-COUNCIL | Testicular Neoplasms - therapy | ras Proteins - genetics | Genome-Wide Association Study | Testicular Neoplasms - genetics | Humans | Neoplasms, Germ Cell and Embryonal - epidemiology | Male | Neoplasms, Germ Cell and Embryonal - genetics | Testicular Neoplasms - epidemiology | Orchiectomy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins c-kit - genetics | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Neoplasms, Germ Cell and Embryonal - therapy | Chemotherapy | Disease susceptibility | Epidemiology | Genomics | Cancer | Tumors | Pathogenesis | Medical prognosis | Genetics | Mutation | Health risk assessment | Testicular cancer | Cancer therapies | Risk factors
Journal Article
2003, American Cancer Society atlas of clinical oncology, ISBN 9781550090826
eBook
American Journal of Surgical Pathology, ISSN 0147-5185, 02/2009, Volume 33, Issue 2, pp. 211 - 217
Embryonal neoplasms of the central nervous system (CNS) generally arise in the early years of life and behave in a clinically aggressive manner, but vary...
Neuropil | Divergent differentiation | Embryonal tumor | Pediatric brain tumors | Ependymoblastic rosettes | neuropil | SURGERY | NEOPLASMS | pediatric brain tumors | embryonal tumor | divergent differentiation | PATHOLOGY | ependymoblastic rosettes | BRAIN-TUMORS | CHILDREN | Immunohistochemistry | Neuropil - pathology | Humans | Brain Neoplasms - pathology | Brain Neoplasms - genetics | Child, Preschool | Infant | Male | Neoplasms, Germ Cell and Embryonal - metabolism | Neoplasms, Germ Cell and Embryonal - genetics | Brain Neoplasms - metabolism | Magnetic Resonance Imaging | Neuroectodermal Tumors - genetics | Female | Neuroectodermal Tumors - pathology | Neoplasms, Germ Cell and Embryonal - pathology | Neuroectodermal Tumors - metabolism
Neuropil | Divergent differentiation | Embryonal tumor | Pediatric brain tumors | Ependymoblastic rosettes | neuropil | SURGERY | NEOPLASMS | pediatric brain tumors | embryonal tumor | divergent differentiation | PATHOLOGY | ependymoblastic rosettes | BRAIN-TUMORS | CHILDREN | Immunohistochemistry | Neuropil - pathology | Humans | Brain Neoplasms - pathology | Brain Neoplasms - genetics | Child, Preschool | Infant | Male | Neoplasms, Germ Cell and Embryonal - metabolism | Neoplasms, Germ Cell and Embryonal - genetics | Brain Neoplasms - metabolism | Magnetic Resonance Imaging | Neuroectodermal Tumors - genetics | Female | Neuroectodermal Tumors - pathology | Neoplasms, Germ Cell and Embryonal - pathology | Neuroectodermal Tumors - metabolism
Journal Article
Cancer Letters, ISSN 0304-3835, 2016, Volume 376, Issue 2, pp. 367 - 376
Highlights • WT1 is under-expressed in TGCT, and has an altered isoform pattern • relapses in chemo-naïve and chemotherapy-pretreated TGCT are of biologic...
Hematology, Oncology and Palliative Medicine | Testicular germ cell tumors | TP53 | Next generation sequencing | KIT | Wilms tumor gene 1 (WT1) | SUPPRESSOR GENE AML | C-KIT | ACUTE MYELOID-LEUKEMIA | MUTATIONAL ANALYSIS | WILMS-TUMOR | P53 | BCL-2 ONCOGENE | ONCOLOGY | DISEASE | EXPRESSION | SEMINOMA | Immunohistochemistry | Prospective Studies | Humans | Male | Neoplasms, Germ Cell and Embryonal - genetics | Testicular Neoplasms - enzymology | DNA Mutational Analysis - methods | Testicular Neoplasms - pathology | Tumor Suppressor Protein p53 - genetics | Feasibility Studies | Neoplasms, Germ Cell and Embryonal - enzymology | Proto-Oncogene Proteins c-kit - genetics | Retrospective Studies | Real-Time Polymerase Chain Reaction | WT1 Proteins - genetics | Genetic Predisposition to Disease | Testicular Neoplasms - genetics | Down-Regulation | Phenotype | Proto-Oncogene Proteins B-raf - genetics | Cell Line, Tumor | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | Mutation | Genes, ras | Neoplasms, Germ Cell and Embryonal - pathology | Chemotherapy | Tumor proteins | Genes | Cancer | Tumors | Germ cell tumors | Disease | Pathogenesis | Surgery | Medical prognosis | Mortality | Metastasis | Cancer therapies | Patients
Hematology, Oncology and Palliative Medicine | Testicular germ cell tumors | TP53 | Next generation sequencing | KIT | Wilms tumor gene 1 (WT1) | SUPPRESSOR GENE AML | C-KIT | ACUTE MYELOID-LEUKEMIA | MUTATIONAL ANALYSIS | WILMS-TUMOR | P53 | BCL-2 ONCOGENE | ONCOLOGY | DISEASE | EXPRESSION | SEMINOMA | Immunohistochemistry | Prospective Studies | Humans | Male | Neoplasms, Germ Cell and Embryonal - genetics | Testicular Neoplasms - enzymology | DNA Mutational Analysis - methods | Testicular Neoplasms - pathology | Tumor Suppressor Protein p53 - genetics | Feasibility Studies | Neoplasms, Germ Cell and Embryonal - enzymology | Proto-Oncogene Proteins c-kit - genetics | Retrospective Studies | Real-Time Polymerase Chain Reaction | WT1 Proteins - genetics | Genetic Predisposition to Disease | Testicular Neoplasms - genetics | Down-Regulation | Phenotype | Proto-Oncogene Proteins B-raf - genetics | Cell Line, Tumor | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | Mutation | Genes, ras | Neoplasms, Germ Cell and Embryonal - pathology | Chemotherapy | Tumor proteins | Genes | Cancer | Tumors | Germ cell tumors | Disease | Pathogenesis | Surgery | Medical prognosis | Mortality | Metastasis | Cancer therapies | Patients
Journal Article
1998, ISBN 082470102X, xiii, 314
Book
The American journal of surgical pathology, ISSN 0147-5185, 2014, Volume 38, Issue 10, pp. 1396 - 1409
Somatic-type malignancies (SMs) in patients with testicular germ cell tumors (GCT) are rare and mostly attributed to "transformation" of teratoma, although...
Immunohistochemistry | Teratoma | Prognosis | Somatic malignancy | Malignant transformation | Yolk sac tumor | Testicular germ cell tumor | UNITED-STATES | TRANSFORMATION | SURGERY | malignant transformation | MARKER | testicular germ cell tumor | somatic malignancy | SPINDLE-CELL | PATHOLOGY | prognosis | yolk sac tumor | TESTIS | immunohistochemistry | teratoma | YOLK-SAC TUMOR | TRANSCRIPTION FACTOR-I | SARCOMATOUS COMPONENTS | EXPRESSION | Predictive Value of Tests | Testicular Neoplasms - mortality | Neoplasms, Glandular and Epithelial - chemistry | Humans | Middle Aged | Male | Testicular Neoplasms - pathology | Neoplasms, Germ Cell and Embryonal - chemistry | Young Adult | Neoplasm Grading | Time Factors | Adult | Endodermal Sinus Tumor - pathology | Testicular Neoplasms - classification | Neoplasms, Germ Cell and Embryonal - mortality | Neoplasms, Glandular and Epithelial - pathology | Neoplasms, Glandular and Epithelial - classification | Biomarkers, Tumor - analysis | Terminology as Topic | Endodermal Sinus Tumor - classification | Endodermal Sinus Tumor - chemistry | Endodermal Sinus Tumor - mortality | Cell Lineage | Biopsy | Adolescent | Neoplasms, Germ Cell and Embryonal - classification | Aged | Testicular Neoplasms - chemistry | Neoplasms, Germ Cell and Embryonal - pathology | Index Medicus
Immunohistochemistry | Teratoma | Prognosis | Somatic malignancy | Malignant transformation | Yolk sac tumor | Testicular germ cell tumor | UNITED-STATES | TRANSFORMATION | SURGERY | malignant transformation | MARKER | testicular germ cell tumor | somatic malignancy | SPINDLE-CELL | PATHOLOGY | prognosis | yolk sac tumor | TESTIS | immunohistochemistry | teratoma | YOLK-SAC TUMOR | TRANSCRIPTION FACTOR-I | SARCOMATOUS COMPONENTS | EXPRESSION | Predictive Value of Tests | Testicular Neoplasms - mortality | Neoplasms, Glandular and Epithelial - chemistry | Humans | Middle Aged | Male | Testicular Neoplasms - pathology | Neoplasms, Germ Cell and Embryonal - chemistry | Young Adult | Neoplasm Grading | Time Factors | Adult | Endodermal Sinus Tumor - pathology | Testicular Neoplasms - classification | Neoplasms, Germ Cell and Embryonal - mortality | Neoplasms, Glandular and Epithelial - pathology | Neoplasms, Glandular and Epithelial - classification | Biomarkers, Tumor - analysis | Terminology as Topic | Endodermal Sinus Tumor - classification | Endodermal Sinus Tumor - chemistry | Endodermal Sinus Tumor - mortality | Cell Lineage | Biopsy | Adolescent | Neoplasms, Germ Cell and Embryonal - classification | Aged | Testicular Neoplasms - chemistry | Neoplasms, Germ Cell and Embryonal - pathology | Index Medicus
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 03/2014, Volume 38, Issue 3, pp. 410 - 420
The SALL4 transcription factor is associated with embryonic cell pluripotency and has been shown as a useful immunohistochemical marker for germ cell tumors....
SURGERY | IMMUNOHISTOCHEMICAL EXPRESSION | MARKER | PLURIPOTENCY | PATHOLOGY | germ cell tumor | CANCER | OCT4 | ONCOGENE | gastric adenocarcinoma | urothelial carcinoma | EARLY EMBRYONIC-DEVELOPMENT | SALL4 | GASTRIC-CARCINOMA | small cell carcinoma | NANOG | immunohistochemistry | serous carcinoma | YOLK-SAC TUMOR | cholangiocarcinoma | UTILITY | ALPHA-FETOPROTEIN | Immunohistochemistry | Predictive Value of Tests | Biomarkers, Tumor - analysis | Humans | Male | Carcinoma - chemistry | Neoplasms, Germ Cell and Embryonal - chemistry | Neoplasm Grading | Biopsy | Adult | Female | Cell Differentiation | Transcription Factors - analysis | Carcinoma - pathology | Neoplasms, Germ Cell and Embryonal - pathology | Index Medicus
SURGERY | IMMUNOHISTOCHEMICAL EXPRESSION | MARKER | PLURIPOTENCY | PATHOLOGY | germ cell tumor | CANCER | OCT4 | ONCOGENE | gastric adenocarcinoma | urothelial carcinoma | EARLY EMBRYONIC-DEVELOPMENT | SALL4 | GASTRIC-CARCINOMA | small cell carcinoma | NANOG | immunohistochemistry | serous carcinoma | YOLK-SAC TUMOR | cholangiocarcinoma | UTILITY | ALPHA-FETOPROTEIN | Immunohistochemistry | Predictive Value of Tests | Biomarkers, Tumor - analysis | Humans | Male | Carcinoma - chemistry | Neoplasms, Germ Cell and Embryonal - chemistry | Neoplasm Grading | Biopsy | Adult | Female | Cell Differentiation | Transcription Factors - analysis | Carcinoma - pathology | Neoplasms, Germ Cell and Embryonal - pathology | Index Medicus
Journal Article